Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL
Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL
Not yet recruiting · NCT05918276 · Registry updated 2023-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL | chronic lymphocytic leukemia/small lymphocytic lymphoma | Not yet recruiting | Phase 2 | 2023-06-26 | NCT05918276 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 248 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hunan Cancer Hospital | Changsha | China | 87 |
| The Central Hospital Of Wuan | Wuhan | China | 1 |